Jane Kalinina

Jane Kalinina

Senior Associate
Washington, D.C.

Email [email protected]​hoganlovells.com

Phone +1 202 637 5461

Fax +1 202 637 5910


Practice groupGlobal Regulatory

Jane Kalinina draws on her interdisciplinary pharmacy and legal experience, bringing a wealth of knowledge to her clients on an array of complex U.S. Food and Drug Administration (FDA) regulatory matters.

Since beginning her legal career, Jane has focused her practice on pharmaceutical and biotechnology product development, biologics license and new drug applications, life cycle management, advertisement and promotional issues, and assisting clients in navigating FDA's intricate regulatory framework. In particular, Jane draws on her scientific background to bring a novel perspective on addressing legal challenges that are heavily intertwined with underlying scientific issues. While attending law school, Jane completed a dual-degree program to receive her Pharm.D. and had previously worked in a research laboratory during her undergraduate studies in microbiology and cell science.

Jane is also part of the firm's Cell, Tissue, and Gene Therapies working group, a cross-disciplinary team that advises companies in this emerging space on the evolving regulatory and business challenges they face. As part of this team, Jane works closely with companies developing stem cells, gene therapies, proteins, and other cellular and tissue products to help people with serious health problems.

Education and admissions


J.D., University of Maryland, Francis King Carey School of Law, 2016

Pharm.D., University of Maryland School of Pharmacy, 2016

B.S., University of Florida, 2010


Member, American Bar Association

Member, Austern Writing Awards Committee, Food and Drug Law Institute (2018-2019)

Editor in Chief, Maryland Journal of International Law, 2016

Bar admissions and qualifications

District of Columbia

Loading data